GNOM
GNOM 1-star rating from Upturn Advisory

Global X Genomics & Biotechnology ETF (GNOM)

Global X Genomics & Biotechnology ETF (GNOM) 1-star rating from Upturn Advisory
$47.36
Last Close (24-hour delay)
Profit since last BUY42.91%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 149 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/09/2026: GNOM (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit 24.79%
Avg. Invested days 63
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
ETF Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/09/2026
Advertisement

Key Highlights

Volume (30-day avg) -
Beta 1.24
52 Weeks Range 6.79 - 11.87
Updated Date 06/30/2025
52 Weeks Range 6.79 - 11.87
Updated Date 06/30/2025
Advertisement

About Global X Genomics & Biotechnology ETF

Exchange NASDAQ
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.